23 elderly people in Norway die after receiving Pfizer COVID-19 vaccine

23 elderly people in Norway die after receiving Pfizer COVID-19 vaccine. Norway’s “NORWAY TODAY” website reported on the 14th local time that the Norwegian Medicines Agency reported that 23 deaths related to vaccines from Pfizer in the United States and BioNTech in Germany had occurred in the country. The deaths were all over the age of 80. Weak elderly population.

On the 15th, a number of medical experts said in an interview with a reporter from the Global Times that the development of mRNA vaccines has been rushed and has never been used on a large scale in the field of infectious disease prevention before. The elderly and infirm should use it with caution. Among them, Japanese experts pointed out that the Japanese government should also consider introducing China’s COVID-19 vaccine.

According to reports, Sigder, chief physician of the Norwegian Medicines Agency, pointed out that fever and nausea are common side effects of mRNA vaccines, which may be the cause of the death of the originally frail elderly. The doctor also said that people who are weak should not get the COVID-19 vaccine.

Professor Yang Zhanqiu of the Institute of Virology of Wuhan University Medical Department said in an interview with a reporter from the Global Times on the 15th that Pfizer vaccines are mRNA vaccines. Compared with inactivated vaccines, there is a big difference in that such vaccines are mainly therapeutic. If the patient has been infected with the new coronavirus or has other diseases, the heterogeneous protein produced by the vaccine may cause allergic reactions and even other side effects, and may also aggravate the underlying disease. This is a recognized shortcoming of mRNA vaccines.

“The deaths of 23 elderly people in Norway depend on their own health. If there are other diseases, the body’s reaction after vaccination is different from that of healthy people. These may be the cause of death.” Yang Zhanqiu said. , Pfizer vaccine passed a large number of tests before entering the clinic. The data at the time showed that it was also safe. However, due to the defects of the therapeutic vaccine itself and the first use of the mRNA vaccine to prevent new coronavirus patients, there is no standard and complete plan for the injection dose. Its safety has a certain impact.

An unnamed immunization expert told the Global Times reporter on the 15th that Pfizer Group’s mRNA COVID-19 vaccine has been developed in a hurry. It has never been used on a large scale in the field of infectious disease prevention before. The elderly and infirm should use it with caution. The expert said that it is not recommended for people over 80 years of age. On the one hand, the immune system itself is too old and the immune system function is insufficient due to aging, and the vaccine effect is not good; at the same time, the immune regulation ability is poor, and immune function disorders are prone to occur. In addition, there are many basic diseases and weak physique, which is more prone to adverse reactions, and the ability to tolerate adverse reactions is also reduced.

Yang Zhanqiu said in an interview that compared with Pfizer vaccine, domestic vaccines are currently mainly inactivated vaccines, which are much safer. This is because the production process of inactivated vaccines is mature, and they are also widely used as preventive vaccines, and the probability of side effects and death is much smaller.

Masahiro Ume, chairman of the Japan Institute of Medical Management, told the Global Times reporter on the 15th that Pfizer vaccine is accompanied by a strong inflammatory response, and the elderly and other weak people must be “quite cautious” when vaccinating.

Japanese Prime Minister Yoshihide Suga stated that the COVID-19 vaccination work will begin nationwide as soon as the end of February, and he himself stated that “we must fight first.” The Japanese government has reached an agreement with Pfizer and plans to provide Japan with 60 million vaccines in the first half of 2021. In this regard, Shang Changguang said, “The vaccination group will give priority to the elderly, but it is not mandatory. As a doctor, I think it should be promoted for individuals, because everyone’s situation is different.”

Hearing that the Chinese people have begun to receive the COVID-19 vaccine of Sinopharm Group, Shang Changguang said, “China is moving fast and it is a symbol of’youth’.” He said that the vaccination work in Japan started too late, and the people may have to wait until after April. Japan, perhaps out of the so-called “face”, has not considered Chinese vaccines so far, which has delayed the time for Japanese people to vaccinate. Japan should also consider introducing Chinese vaccines. One more option means one more option.

(source:internet, reference only)

Disclaimer of medicaltrend.org